Nathan P. Wiederhold

This study establishes CLSI-endorsed epidemiological cutoff values (ECVs) for antifungal susceptibility in clinically relevant Sporothrix species using broth microdilution data from 19 laboratories.

This study evaluates SQ109's antifungal activity against sixteen fungal pathogens and identifies its mechanisms involving mitochondrial targeting and isoprenoid biosynthesis pathway inhibition.

The paper identifies mutations in transcription factors that confer fluconazole resistance and also reduce susceptibility to manogepix in multiple Candida species.

This study characterizes two clinical Sarocladium spinificis strains that inhibit Coccidioides posadasii growth, revealing their genomic features and potential antifungal properties.